UBS maintained its buy rating on Palantir and raised its price target from $220 to $250, the third upward revision this year according to analyst Karl Keirstead. The company posted $3.4 billion in bookings for Q2 2026, with net dollar retention at 157% and adjusted operating margins exceeding 60%. Palantir also raised its full-year 2026 revenue guidance by $500 million to a range of $8.15 to $8.16 billion. The analyst highlighted the growing concept of AI sovereignty, as enterprises and governments seek greater control over their data and AI infrastructure. The broader Wall Street consensus remains more cautious with an average price target around $194 and a Moderate Buy rating.
Source: Read the original article
